Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) EPS (Basic) : ¥0.24 (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Hainan Huluwa Pharmaceutical Group Co EPS (Basic)?

Hainan Huluwa Pharmaceutical Group Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was ¥0.07. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.24.

Hainan Huluwa Pharmaceutical Group Co's EPS (Diluted) for the three months ended in Mar. 2024 was ¥0.07. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.24.

Hainan Huluwa Pharmaceutical Group Co's EPS without NRI for the three months ended in Mar. 2024 was ¥0.07. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was 0.30.

During the past 12 months, Hainan Huluwa Pharmaceutical Group Co's average EPS without NRIGrowth Rate was 16.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was -3.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was -13.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Hainan Huluwa Pharmaceutical Group Co's highest 3-Year average EPS without NRI Growth Rate was 17.10% per year. The lowest was -25.90% per year. And the median was -15.20% per year.

Hainan Huluwa Pharmaceutical Group Co EPS (Basic) Historical Data

The historical data trend for Hainan Huluwa Pharmaceutical Group Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Huluwa Pharmaceutical Group Co EPS (Basic) Chart

Hainan Huluwa Pharmaceutical Group Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

0.33

0.32

0.18

0.21

0.27

Hainan Huluwa Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Basic)	Get a 7-Day Free Trial															0.10	0.05	0.04	0.08	0.07

Hainan Huluwa Pharmaceutical Group Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Hainan Huluwa Pharmaceutical Group Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(106.498	-	0)	/	394.436
	=	0.27

Hainan Huluwa Pharmaceutical Group Co's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(29.032	-	0)	/	414.750
	=	0.07

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.24

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Hainan Huluwa Pharmaceutical Group Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Hainan Huluwa Pharmaceutical Group Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Huluwa Pharmaceutical Group Co Ltd (SHSE:605199) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

No. 8, Yaogu 4th Road, Phase II, Yaogu Industrial Park, Haikou National High-tech Zone, Hainan Province, Haikou, CHN, 570300

Website

http://www.huluwayaoye.com

Hainan Huluwa Pharmaceutical Group Co Ltd is engaged in production and sales of Chinese patent medicines and chemical drugs. The company produces medicines for children's respiratory and digestive systems. Its products include star products, calabash, gourd dad, and gourd mom.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Headlines

No Headlines